Aims and Background Aesthetic medicine has undergone remarkable growth, yet the clinical infrastructure supporting the patient encounter has not kept pace with the sophistication of the patients seeking care. Today’s aesthetic patient is highly educated, visually literate, and accustomed to data-driven decision-making. They arrive with expectations that the standard clinical encounter — built on subjective assessment and verbal consultation — has not consistently been designed to meet. Technology This review examines emerging technologies in skin and facial analysis and presents the evidence-based case for their adoption across the full patient care continuum, from pre-consultation through post-treatment follow-through. Patient Selection Technologies are organized by clinical function: in-office skin analysis systems, three-dimensional volumetric imaging and simulation, artificial intelligence facial scoring and proportion analysis platforms, and advanced tissue characterization modalities. A three-phase framework — pre-consultation, consultation, and post-treatment — structures the case for adoption and its implications for patient selection, informed consent, and longitudinal care. Conclusions and Clinical Relevance New technologies in skin and facial analysis offer meaningful clinical benefit across the full patient encounter. The evidence consistently supports that technology-augmented encounters produce better-informed patients, stronger clinical trust, and more defensible outcomes. Technology does not replace the surgeon-patient relationship — it amplifies it.
Naina Tanya Judge (Mon,) studied this question.